Granulated mesalamine ( DrugBank: Mesalamine )


1 disease
IDDisease name (Link within this page)Number of trials
97Ulcerative colitis2

97. Ulcerative colitis


Clinical trials : 2,527 Drugs : 1,465 - (DrugBank : 259) / Drug target genes : 144 - Drug target pathways : 202
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00767728
(ClinicalTrials.gov)
December 200417/9/2008Mesalamine Pellet to Maintain Remission of Mild to Moderate Ulcerative ColitisA Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Use of Mesalamine Pellet Formulation 1.5G QD to Maintain Remission From Mild to Moderate Ulcerative ColitisUlcerative ColitisDrug: Granulated mesalamine;Drug: PlaceboBausch Health Americas, Inc.NULLCompleted18 YearsN/AAll256Phase 3United States
2NCT00744016
(ClinicalTrials.gov)
December 200427/8/2008Mesalamine Pellet Formulation to Maintain Remission of Mild to Moderate Ulcerative ColitisA Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Use of Mesalamine Pellet Formulation 1.5G QD to Maintain Remission From Mild to Moderate Ulcerative ColitisUlcerative ColitisDrug: Granulated mesalamine;Drug: PlaceboBausch Health Americas, Inc.NULLCompleted18 YearsN/AAll305Phase 3United States